Published: November 2025
Over the past decade, the medical device industry has experienced a surge in research and innovation driven by numerous scientific and technological breakthroughs. This progress, coupled with the increasing disease burden on healthcare systems, has heightened the demand for advanced and minimally invasive medical devices. However, one of the primary challenges faced by this industry is the complex and time-consuming product development lifecycle for new medical devices. The clinical stage, in particular, is resource-intensive, involving significant costs and substantial risks. Additionally, new advancements have facilitated the development and enforcement of more informed regulatory guidelines and instructions to ensure the safety of medical devices.
However, regulatory guidelines vary across various geographical regions, posing further challenges for medical device developers seeking approval in multiple markets. This often results in longer clinical trials, higher costs (due to a rise in patient enrollments), and extended time-to-market. To address these challenges, many medical device developers are actively outsourcing clinical research and related operations to contract service providers, that possess the necessary expertise and capabilities to navigate these complexities.
Notably, CROs can vary significantly in terms of their capabilities, ranging from large, international, full-service providers to small, niche CROs with specific areas of expertise. These organizations usually enable their sponsor companies to achieve cost and time savings while conducting clinical trials. Moreover, outsourcing R&D activities helps medical device developers to focus on their core operations, such as distribution and sales, within their organization. In certain instances, sponsors might also outsource clinical trials if they lack the requisite regulatory expertise in a particular country of interest or if the regulatory structure requires them to have a legal presence in that country. Some of the key services offered by CROs include clinical site monitoring, clinical trial management, consulting, data management, R&D services, regulatory management, patient recruitment and product development.
Roots Analysis has conducted an exhaustive study on Medical Device CRO Market featuring the current market landscape and future opportunity for the companies engaged in healthcare, over a span of next 10 years.

Interested in exploring all ~380 players offering medical device related services, along with their recent initiatives?
Let us dive deep into the details of the top 5 medical device CRO companies. It is essential to note that the selection of top players can differ substantially according to the defined criteria.
Company Overview
Avania is a privately held company that offers clinical research services for the development of various medical devices (including combination products). The company leverages its extensive expertise in the development of medical devices across various therapeutic areas, such as bone disorders, cardiovascular disorders, dental disorders, metabolic disorders, neurological disorders, oncological disorders, ophthalmological disorders, skin disorders and urological disorders. It is worth noting that the company has assisted various medical device companies in obtaining breakthrough designation for more than 30 medical devices. Further, the company supports its clients across the globe through its offices in Australia, Canada, Germany, the Netherlands, New Zealand, Spain and the US.
List of Type of Clinical Services Offered
The section provides information on the various types of clinical services being offered by Avania.
Recent Developments
In September 2025, Avania announced the appointment of four new executives to the team, in order to bring expertise to meet the growing demand for MedTech clinical and regulatory expertise.
To know more about the recent initiatives of Avania and other medical device CRO companies, access full report.
Company Overview
Eurofins Medical Device Testing (a subsidiary of Eurofins Scientific) is a US-based company that claims to offer a broad range of analytical testing and laboratory services to biopharmaceutical, food and beverage, medical device, nutraceutical and pharmaceutical industries. Notably, the company has a global presence across nearly 65 countries and is equipped with global capacity of more than 200,000 square meters. In addition, the company adheres to various regulatory standards, including ISO and GMP and follow guidelines set forth by European and British Pharmacopeia (EP and BP), United States Pharmacopeia (USP) and Japanese Pharmacopeia (JP). In addition to this, the network of Eurofins Medical Device Testing is well-equipped to support medical device testing across various target indications.
List of Type of Clinical Services Offered
The section provides information on the various types of clinical services being offered by Eurofins Medical Device Testing.
Recent Developments
In October 2025, Eurofins Medical Device Services Europe announced the acquisition of ac.biomed, a specialized testing laboratory for CVD medical devices.
To know more about the recent initiatives of Eurofins Medical Device Testing and other medical device CRO companies, access full report.
Company Overview
NAMSA is a privately-held company, which offers end-to-end development services for medical devices (including combination products and in vitro diagnostic devices) and regenerative medicines. Notably, the company positions itself as a single-source provider, assisting medical device companies through the entire development process from design to commercialization along with addressing post-market requirements. It is worth noting that, in February 2025, Tigermed-Jyton announced the acquisition of NAMSA China in order to enhance the former company’s capabilities and expand its geographical reach.
List of Type of Clinical Services Offered
The section provides information on the various types of clinical services being offered by NAMSA.
Recent Developments
In March 2025, NAMSA completed the acquisition of US medical device testing business operations of WuXi Apptec.
To know more about the recent initiatives of NAMSA and other medical device CRO companies, access full report.
Company Overview
SGS, headquartered in Geneva, claims to be a global leader in testing and inspection, providing comprehensive clinical research services for various medical devices. Notably, the company also provides regulatory compliance support through advanced tools along with certifications, such as GMP. Notably, the company leverages its various ISO / IEC 17025 accredited laboratories across the world and offers cutting-edge technologies with expert guidance to assist clients in navigating the complex medical device landscape, while also offering training programs to enhance industry knowledge.
List of Type of Clinical Services Offered
The section provides information on the various types of clinical services being offered by SGS.
Recent Developments
In January 2025, SGS received the approval for extending the scope of EU Medical Device Regulation (MDR) sterilization services which will include dry heat, as per EN 20857; vaporized hydrogen peroxide, as per ISO 22441; low-temperature steam and formaldehyde, as per EN ISO 25242’; chlorine dioxide, as per EN ISO 14937; nitrogen dioxide, as per EN ISO 14937; and supercritical carbon dioxide, as per EN ISO 14937.
To know more about the recent initiatives of SGS and other medical device CRO companies, access full report.
Company Overview
UL Solutions is a US-based company engaged in offering testing, inspection and certification services to the biopharmaceutical and medical device companies. The company has its global presence in more than 110 countries to assist various industries, including automotive, consumer technologies, energy, environmental, life sciences, industrial, and medical industry. It is worth noting that the company offers eLearning modules and seminars to assist their clients with a deeper knowledge of medical device development processes, as well as to foster a shared understanding of best practices in medical device development.
List of Type of Clinical Services Offered
The section provides information on the various types of clinical services being offered by UL Solutions.
Recent Developments
In March 2025, UL Solutions announced the expansion of Songshan lake IoT laboratory in China so as support the manufacturers to navigate complexities associated with connected products and wireless device testing and market access.
To know more about the recent initiatives of UL Solutions and other medical device CRO companies, access full report.
The above article features the top five medical device CRO companies selected from a pool of around 380 companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
Sources: